Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

64.02
-2.4800-3.73%
Volume:726.02K
Turnover:47.18M
Market Cap:12.54B
PE:-17.94
High:66.41
Open:66.39
Low:63.87
Close:66.50
52wk High:93.42
52wk Low:52.75
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.64
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-4.98
PE(LYR):-16.91

Loading ...

Bridgebio Shareholders Approved 2 Million-share Increase Under 2021 Equity Plan at Annual Meeting

Reuters
·
Jun 26

Bridgebio Director Hannah Valantine Disposes of Common Shares Worth $341,571.72

Reuters
·
Jun 25

BRIEF-Bridgebio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jun 24

BridgeBio Pharma grants 66,810 restricted stock units to 30 new employees under inducement plan

Reuters
·
Jun 24

BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 24

BridgeBio Oncology Therapeutics shareholders elect Lebowitz, McCormick to board

Reuters
·
Jun 23

Movement Alert|BridgeBio Pharma Rises 5.04% in Regular Trading, Trading at $69.625

Market Focus
·
Jun 23

BridgeBio to present Phase 3 PROPEL 3 trial results for oral infigratinib in children with achondroplasia at ICCBH 2026

Reuters
·
Jun 22

BridgeBio director Jennifer E. Cook disposes of common shares worth $6,011,959.36

Reuters
·
Jun 18

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BridgeBio Pharma (BBIO) and Guardant Health (GH)

TIPRANKS
·
Jun 17

BridgeBio Pharma Inc : Mizuho Cuts Target Price to $96 From $106

THOMSON REUTERS
·
Jun 16

U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation

Reuters
·
Jun 16

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and BridgeBio Pharma (BBIO)

TIPRANKS
·
Jun 16

BRIEF-DKSH Enters Strategic Distribution Partnership With Bridgebio

Reuters
·
Jun 11

DKSH partners with BridgeBio to distribute ATTR-CM transthyretin stabilizer in Asia-Pacific markets

Reuters
·
Jun 11

BridgeBio CEO Neil Kumar reports $4.26 million common share disposal

Reuters
·
Jun 09

Barclays Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Jun 05

How FDA Priority Review for First-in-Class LGMD Drug BBP-418 Could Impact BridgeBio Pharma (BBIO) Investors

Simply Wall St.
·
Jun 05

BridgeBio Pharma Inc : Canaccord Genuity Initiates Coverage With Buy Rating; Price Target $104

THOMSON REUTERS
·
Jun 03

Canaccord Genuity Initiates BridgeBio Pharma at Buy With $104 Price Target

MT Newswires Live
·
Jun 03